• 1
    Wemyss-Holden SA, Dennison AR, Berry DP, Maddern GJ. Local ablation for unresectable liver tumors: is thermal best? J Hepatobiliary Pancreat Surg 2004; 11: 97106.
  • 2
    Fuchs EJ, Matzinger P. Is cancer dangerous to the immune system? Semin Immunol 1996; 8: 27180.
  • 3
    Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 124955.
  • 4
    Schueller G, Kettenbach J, Sedivy R, et al. Heat shock protein expression induced by percutaneous radiofrequency ablation of hepatocellular carcinoma in vivo. Int J Oncol 2004; 24: 60913.
  • 5
    Schueller G, Kettenbach J, Sedivy R, et al. Expression of heat shock proteins in human hepatocellular carcinoma after radiofrequency ablation in an animal model. Oncol Rep 2004; 12: 4959.
  • 6
    Harding CV. Class I MHC presentation of exogenous antigens. J Clin Immunol 1996; 16: 906.
  • 7
    Hansler J, Wissniowski TT, Schuppan D, et al. Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases. World J Gastroenterol 2006; 12: 371621.
  • 8
    Hansler J, Neureiter D, Strobel D, et al. Cellular and vascular reactions in the liver to radiofrequency thermo-ablation with wet needle applicators. Study on juvenile domestic pigs. Eur Surg Res 2002; 34: 35763.
  • 9
    Wissniowski TT, Hänsler J, Neureiter D, et al. Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res 2003; 63: 6496500.
  • 10
    Den Brok MH, Sutmuller RP, Van Der Voort R, et al. In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 2004; 64: 40249.
  • 11
    Ali MY, Grimm CF, Ritter M, et al. Activation of dendritic cells by local ablation of hepatocellular carcinoma. J Hepatol 2005; 43: 81722.
  • 12
    Den Brok MH, Sutmuller RP, Nierkens S, et al. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br J Cancer 2006; 95: 896905.
  • 13
    Zerbini A, Pilli M, Fagnoni F, et al. Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation. J Immunother 2008; 31: 27182.
  • 14
    Zerbini A, Pilli M, Penna A, et al. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 2006; 66: 113946.
  • 15
    Napoletano C, Taurino F, Biffoni M, et al. RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients. Int J Oncol 2008; 32: 48190.
  • 16
    Dong B, Zhang J, Liang P, et al. Influencing factors of local immunocyte infiltration in hepatocellular carcinoma tissues pre- and post-percutaneous microwave coagulation therapy. Zhonghua Yi Xue Za Zhi 2002; 82: 3937.
  • 17
    Szmigielski S, Sobczynski J, Sokolska G, et al. Effects of local prostatic hyperthermia on human NK and T cell function. Int J Hyperthermia 1991; 7: 86980.
  • 18
    Nakayama J, Kokuba H, Kobayashi J, Yoshida Y, Hori Y. Experimental approaches for the treatment of murine B16 melanomas of various sizes. I: local injection of ethanol with a combination of interleukin-2 or microwaval hyperthermia for B16 melanomas with a size of less than 7 mm in diameter. J Dermatol Sci 1997; 15: 7581.
  • 19
    Nakayama J, Kokuba H, Kobayashi J, Yoshida Y, Hori Y. Experimental approaches for the treatment of murine B16 melanomas of various sizes. II: injection of ethanol with combinations of beta-interferon and microwaval hyperthermia for B16 melanomas with a size of greater than 10 mm in diameter. J Dermatol Sci 1997; 15: 828.
  • 20
    Dong BW, Zhang J, Liang P, et al. Sequential pathological and immunologic analysis of percutaneous microwave coagulation therapy of hepatocellular carcinoma. Int J Hyperthermia 2003; 19: 11933.
  • 21
    Zhang J, Dong B, Liang P, et al. Significance of changes in local immunity in patients with hepatocellular carcinoma after percutaneous microwave coagulation therapy. Chin Med J 2002; 115: 136771.
  • 22
    Dong B, Zhang J, Liang P. Effect of percutaneous microwave coagulation therapy on local immune response in patients with hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi 2000; 80: 7458.
  • 23
    Zhang J, Dong B, Liang P. Functional assessment of infiltrating immunocytes in patients with primary hepatocellular carcinoma after percutaneous microwave coagulation therapy. Zhonghua Yi Xue Za Zhi 2001; 81: 9747.
  • 24
    Hong X, Baowei D, Xingshi L. Changes of T-lymphocyte subsets in patients with liver cancer treated by ultrasound-guide percutaneous microwave coagulation. Chin J Phys Ther 2000; 1: 157.
  • 25
    Soanes WA, Ablin RJ, Gonder MJ. Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J Urol 1970; 104: 1549.
  • 26
    Sarantou T, Bilchik A, Ramming KP. Complications in hepatic cryosurgery. Semin Surg Oncol 1998; 14: 15662.
  • 27
    Haddad FF, Chapman WC, Blair TK, Wright JK, Pinson CW. Clinical experience with cryosurgery for advanced hepatobiliary tumors. J Surg Res 1998; 75: 1038.
  • 28
    Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999; 23: 10914.
  • 29
    Chapman WC, Debelak JP, Wright Pinson C, et al. Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. Ann Surg 2000; 231: 75261.
  • 30
    Ravindranath MH, Wood TF, Soh D, et al. Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments antiganglioside IgM. Cryobiology 2002; 45: 1021.
  • 31
    Den Brok MH, Sutmuller RP, Nierkens S, et al. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine. Cancer Res 2006; 66: 728592.
  • 32
    Evrard S, Menetrier-Caux C, Biota C, et al. Cytokines pattern after surgical radiofrequency ablation of liver colorectal metastases. Gastroenterol Clin Biol 2007; 31: 1415.
  • 33
    Schell SR, Wessels FJ, Abouhamze A, Moldawer LL, Copeland EM III. Pro- and antiinflammatory cytokine production after radiofrequency ablation of unresectable hepatic tumors. J Am Coll Surg 2002; 195: 77481.
  • 34
    Meredith K, Haemmerich D, Qi C, Mahvi D. Hepatic resection but not radiofrequency ablation results in tumor growth and increased growth factor expression. Ann Surg 2007; 245: 7716.
  • 35
    Schueller G, Stift A, Friedl J, et al. Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells. Int J Oncol 2003; 22: 1397402.
  • 36
    Chapman WC, Debelak JP, Blackwell TS, et al. Hepatic cryoablation-induced acute lung injury: pulmonary hemodynamic and permeability effects in a sheep model. Arch Surg 2000; 135: 66772.
  • 37
    Seifert JK, Stewart GJ, Hewitt PM, et al. Interleukin-6 and tumor necrosis factor-alpha levels following hepatic cryotherapy: association with volume and duration of freezing. World J Surg 1999; 23: 101926.
  • 38
    Seifert JK, France MP, Zhao J, et al. Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg 2002; 26: 133341.
  • 39
    Sadikot RT, Wudel LJ, Jansen DE, et al. Hepatic cryoablation-induced multisystem injury: bioluminescent detection of NF-kappaB activation in a transgenic mouse model. J Gastrointest Surg 2002; 6: 26470.
  • 40
    Blackwell TS, Debelak JP, Venkatakrishnan A, et al. Acute lung injury after hepatic cryoablation: correlation with NF-kappa B activation and cytokine production. Surgery 1999; 126: 51826.
  • 41
    Wudel LJ Jr, Allos TM, Washington MK, Sheller JR, Chapman WC. Multi-organ inflammation after hepatic cryoablation in BALB/c mice. J Surg Res 2003; 112: 1317.
  • 42
    De Jong KP, Von Geusau BA, Rottier CA, et al. Serum response of hepatocyte growth factor, insulin-like growth factor-I, interleukin-6, and acute phase proteins in patients with colorectal liver metastases treated with partial hepatectomy or cryosurgery. J Hepatol 2001; 34: 4227.
  • 43
    Huang A, McCall JM, Weston MD, et al. Phase I study of percutaneous cryotherapy for colorectal liver metastasis. Br J Surg 2002; 89: 30310.
  • 44
    Washington K, Debelak JP, Gobbell C, et al. Hepatic cryoablation-induced acute lung injury: histopathologic findings. J Surg Res 2001; 95: 17.
  • 45
    Ng KK, Lam CM, Poon RT, et al. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model. Ann Surg Oncol 2004; 11: 6507.
  • 46
    Ng KK, Lam CM, Poon RT, et al. Safety limit of large-volume hepatic radiofrequency ablation in a rat model. Arch Surg 2006; 141: 2528.
  • 47
    Kallio R, Sequeiros R, Surcel HM, et al. Early cytokine responses after percutaneous magnetic resonance imaging guided laser thermoablation of malignant liver tumors. Cytokine 2006; 34: 27883.
  • 48
    Teague BD, Court FG, Morrison CP, et al. Electrolytic liver ablation is not associated with evidence of a systemic inflammatory response syndrome. Br J Surg 2004; 91: 17883.
  • 49
    Sadamori H, Yagi T, Kanaoka Y, et al. The analysis of the usefulness of laparoscopic microwave coagulation therapy for hepatocellular carcinoma in patients with poor hepatic reserve by serial measurements of IL-6, cytokine antagonists, and C-reactive protein. Surg Endosc 2003; 17: 5104.
  • 50
    Chiriva-Internati M, Liu Y, Salati E, et al. Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells. Eur J Immunol 2002; 32: 308.
  • 51
    Fisher-Adams G, Wong KK Jr, Podsakoff G, Forman SJ, Chatterjee S. Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction. Blood 1996; 88: 492504.
  • 52
    Mazzolini G, Alfaro C, Sangro B, et al. Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas. J Clin Oncol 2005; 23: 9991010.
  • 53
    Weide B, Garbe C, Rammensee HG, Pascolo S. Plasmid DNA- and messenger RNA-based anti-cancer vaccination. Immunol Lett 2008; 115: 3342.
  • 54
    Shu S, Zheng R, Lee WT, Cohen PA. Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy. Crit Rev Immunol 2007; 27: 46383.
  • 55
    Roback JD. Vaccine-enhanced donor lymphocyte infusion (veDLI). Hematol Am Soc Hematol Educ Program 2006; 48691, 513.
  • 56
    Copier J, Dalgleish A. Overview of tumor cell-based vaccines. Int Rev Immunol 2006; 25: 297319.
  • 57
    Rughetti A, Rahimi K, Rossi P, et al. Modulation of blood circulating immune cells by radiofrequency tumour ablation. J Exp Clin Cancer Res 2003; 22(4 Suppl.): 24750.